← Leaderboards
Muxiang Zhou
Emory University
$8,074,026
Attributed
$11,070,854
Total exposure
6
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2008–25$2M$1.5M$1M$500K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$11,070,854 · 6
By mechanism
R01$11,070,854 · 6
Top collaborators
- Wei Li5 shared
- Binghe Wang5 shared
- Douglas K Graham2 shared
Others in their field
Top investigators on “Apoptosis”
- David Heimbrook · Leidos Biomedical Research, Inc.$49,205,802
- Jay A Nelson · Oregon Health & Science University$45,942,124
- John C Reed · University Of Texas Md Anderson Can Ctr$34,437,189
- John A Tainer · Scripps Research Institute$30,637,655
- Henry Shelton Earp · Univ Of North Carolina Chapel Hill$28,872,594
- John D Minna · University Of Texas Sw Med Ctr/Dallas$27,317,167
Research focus
ApoptosisDrug ResistanceMalignant NeoplasmsCancer CellOverexpressionMolecularMdm2 GeneCancer TherapyRefractoryApoptoticPlayBaseNovel TherapeuticsDesignCell SurvivalResistanceRegulationCellsPharmaceutical PreparationsProteinsTp53 GeneCancer PatientIn VivoInnovation
Grant awards (33)
Discovery of a novel MDM2-tubulin signaling pathway as a therapeutic target in AML$538,185
R01 · FY2025 · CA · contact PI
Discovery of a novel MDM2-tubulin signaling pathway as a therapeutic target in AML$554,143
R01 · FY2024 · CA · contact PI
Dual inhibition of MDM2 and XIAP as a therapeutic strategy in cancer$514,428
R01 · FY2024 · CA
Dual inhibition of MDM2 and XIAP as a therapeutic strategy in cancer$530,672
R01 · FY2023 · CA
Dual inhibition of MDM2 and XIAP as a therapeutic strategy in cancer$530,672
R01 · FY2022 · CA
Dual inhibition of MDM2 and XIAP as a therapeutic strategy in cancer$541,500
R01 · FY2021 · CA
Dual inhibition of MDM2 and XIAP as a therapeutic strategy in cancer$554,502
R01 · FY2020 · CA
Novel anthraquinones induce apoptosis by disruption MDM2/MDM4 interactions$442,311
R01 · FY2018 · CA
Novel anthraquinones induce apoptosis by disruption MDM2/MDM4 interactions$442,311
R01 · FY2017 · CA
Regulation of MDM2 auto-ubiquitination and molecular targeting$251,191
R01 · FY2017 · CA · contact PI
Novel anthraquinones induce apoptosis by disruption MDM2/MDM4 interactions$442,311
R01 · FY2016 · CA
Regulation of MDM2 auto-ubiquitination and molecular targeting$251,191
R01 · FY2016 · CA · contact PI
Novel anthraquinones induce apoptosis by disruption MDM2/MDM4 interactions$442,311
R01 · FY2015 · CA
Regulation of MDM2 auto-ubiquitination and molecular targeting$251,191
R01 · FY2015 · CA · contact PI
Berberine downregulates MDM2 by interaction with DAXX in cancer cells$237,269
R01 · FY2015 · CA · contact PI
Novel anthraquinones induce apoptosis by disruption MDM2/MDM4 interactions$460,311
R01 · FY2014 · CA
Regulation of MDM2 auto-ubiquitination and molecular targeting$243,655
R01 · FY2014 · CA · contact PI
Berberine downregulates MDM2 by interaction with DAXX in cancer cells$65,349
R01 · FY2014 · CA · contact PI
Berberine downregulates MDM2 by interaction with DAXX in cancer cells$293,258
R01 · FY2013 · CA · contact PI
Regulation of MDM2 auto-ubiquitination and molecular targeting$251,191
R01 · FY2013 · CA · contact PI
Berberine downregulates MDM2 by interaction with DAXX in cancer cells$311,976
R01 · FY2012 · CA · contact PI
MDM2 regulates XIAP gene expression in cancer treatment$249,581
R01 · FY2012 · CA · contact PI
Berberine downregulates MDM2 by interaction with DAXX in cancer cells$311,976
R01 · FY2011 · CA · contact PI
MDM2 regulates XIAP gene expression in cancer treatment$249,581
R01 · FY2011 · CA · contact PI
Berberine downregulates MDM2 by interaction with DAXX in cancer cells$321,625
R01 · FY2010 · CA · contact PI
MDM2 regulates XIAP gene expression in cancer treatment$257,300
R01 · FY2010 · CA · contact PI
MDM2 regulates XIAP gene expression in cancer treatment$257,300
R01 · FY2009 · CA · contact PI
MDM2 regulates XIAP gene expression in cancer treatment$256,678
R01 · FY2008 · CA · contact PI
MUTUAL REGULATION OF P53, MDM2 AND NFKB:$202,943
R01 · FY2004 · CA
MUTUAL REGULATION OF P53, MDM2 AND NFKB:$202,943
R01 · FY2003 · CA
MUTUAL REGULATION OF P53, MDM2 AND NFKB:$202,943
R01 · FY2002 · CA
MUTUAL REGULATION OF P53, MDM2 AND NFKB:$203,499
R01 · FY2001 · CA
MUTUAL REGULATION OF P53, MDM2 AND NFKB:$204,557
R01 · FY2000 · CA